Catheter Precision (VTAK) Short term Debt (2025 - 2026)
Catheter Precision (VTAK) reported Short term Debt of $298000.0 for Q1 2026, little changed on a QoQ basis from $298000.0 in Q4 2025.
Catheter Precision (VTAK) has 2 years of Short term Debt data on file, last reported at $298000.0 in Q1 2026.
- Quarterly Short term Debt changed N/A year-over-year to $298000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $298000.0 (changed N/A YoY) and the FY2025 annual result came in at $298000.0, changed N/A from the prior year.
- Short term Debt was little changed at $298000.0 in Q1 2026 per VTAK's latest filing, from $298000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $298000.0 in Q4 2025 and bottomed at $298000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 298,000.00 |
| Dec 31, 2025 | 298,000.00 |